Document is current
Any future updates will be listed below
-
Authors
Fatulla, Pavel
Ludvigsson, Johnny
Imberg, Henrik
Nyström, Thomas
Lind, Marcus https://orcid.org/0000-0002-3796-9283
-
Funding
Funding for this research was provided by:
University of Gothenburg
- License Information
-
More Information
Article History
Received: 9 June 2025
Accepted: 27 July 2025
First Online: 17 September 2025
Declarations
:
: Dr Nyström reported receiving honoraria from AstraZeneca, Merck Sharp & Dohme, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Abbott, and Amgen. Dr Lind reported receiving grants from Eli Lilly, grants from Novo Nordisk and consulting fees from Boehringer Ingelheim, Eli Lilly, Nordicinfu Care AB, Novo Nordisk, and Rubin Medical outside the submitted work. No other disclosures were reported.
: All procedures were conducted in adherence to local ethical standards and in accordance with the 1964 Helsinki Declaration and its subsequent amendments.
: Each author confirms their contribution as listed, and all authors have reviewed and approved the final manuscript for submission.
